Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Surveillance HeartCare® Outcomes Registry

← catalyst calendar

NCT03695601 · readout ≤ 103 d

Sponsored by CareDx (industry) · CDNA — their whole pipeline →.

Phase
Status
Active, not recruiting
Study type
Observational
Enrollment
2,743estimated
Sites
67
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2018-12-28actualWhen the study began enrolling
Primary completionNov 2026estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completionNov 2026estimatedThe whole study's end, after follow-up
First posted2018-10-04actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-05-27actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Heart Transplant Rejection

Intervention

  • Other: Standard of Care

Primary outcome

what the primary-completion date above is the date OF
Proportion of patients who develop de-novo DSA as a surrogate to clinical outcomes at 1, 3 and 5 years post-transplant.
measured Dec-2026

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · CDNA's whole pipeline · Catalyst calendar · Every registered study · What changed